A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting (Q43885713)

From Wikidata

Jump to navigation Jump to search

scientific article published in December 2001

Language	Label	Description	Also known as
English	A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting	scientific article published in December 2001

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting (English)

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Alzheimer's disease

0 references

0 references

1 reference

based on heuristic

inferred from title

author name string

Tariot PN

1

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Cummings JL

2

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Katz IR

3

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Mintzer J

4

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Perdomo CA

5

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Schwam EM

6

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Whalen E

7

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Journal of the American Geriatrics Society

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

49

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

1590-1599

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Dementia caregiver burden: a review of the literature and guidelines for assessment and intervention

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Incontinence and troublesome behaviors predict institutionalization in dementia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Prevalence of mental illness in a community nursing home.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Mental disorders in the nursing home: another perspective.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Potential cost savings in residential care for Alzheimer's disease patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Cholinesterase inhibitors: A new class of psychotropic compounds

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

A 24-week, double-blind, placebo-controlled trial of donepezil in patients with Alzheimer's disease. Donepezil Study Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Validation of the Cumulative Illness Rating Scale in a geriatric residential population

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

The Clinical Dementia Rating (CDR): current version and scoring rules

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Longitudinal evaluation of dementia of the Alzheimer type: a comparison of 3 standardized mental status examinations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1532-5415.2001.49266.X

21 January 2018

Identifiers

10.1111/J.1532-5415.2001.49266.X

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

27 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43885713&oldid=2104153262"